Spots Global Cancer Trial Database for stage ivb rectal cancer

Every month we try and update this database with for stage ivb rectal cancer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Relationship Between Platinum Levels in the Blood and Neurotoxicity in Patients Who Are Receiving Oxaliplatin for Gastrointestinal Cancer	NCT00274885	Cancer	oxaliplatin management of t...	18 Years -	National Cancer Institute (NCI)
Family Caregiver Palliative Care Intervention in Supporting Caregivers of Patients With Stage II-IV Gastrointestinal, Gynecologic, Urologic and Lung Cancers	NCT01846520	Healthy Subject Localized Trans... Metastatic Tran... Psychosocial Ef... Recurrent Bladd... Recurrent Cervi... Recurrent Colon... Recurrent Gastr... Recurrent Ovari... Recurrent Ovari... Recurrent Pancr... Recurrent Recta... Recurrent Renal... Recurrent Trans... Recurrent Ureth... Recurrent Uteri... Regional Transi... Stage II Bladde... Stage II Renal ... Stage II Urethr... Stage IIA Cervi... Stage IIA Colon... Stage IIA Gastr... Stage IIA Ovari... Stage IIA Ovari... Stage IIA Pancr... Stage IIA Recta... Stage IIA Uteri... Stage IIB Cervi... Stage IIB Colon... Stage IIB Gastr... Stage IIB Ovari... Stage IIB Ovari... Stage IIB Pancr... Stage IIB Recta... Stage IIB Uteri... Stage IIC Colon... Stage IIC Ovari... Stage IIC Ovari... Stage IIC Recta... Stage III Bladd... Stage III Pancr... Stage III Renal... Stage III Ureth... Stage IIIA Cerv... Stage IIIA Colo... Stage IIIA Gast... Stage IIIA Ovar... Stage IIIA Ovar... Stage IIIA Rect... Stage IIIA Uter... Stage IIIB Cerv... Stage IIIB Colo... Stage IIIB Gast... Stage IIIB Ovar... Stage IIIB Ovar... Stage IIIB Rect... Stage IIIB Uter... Stage IIIC Colo... Stage IIIC Gast... Stage IIIC Ovar... Stage IIIC Ovar... Stage IIIC Rect... Stage IIIC Uter... Stage IV Bladde... Stage IV Gastri... Stage IV Ovaria... Stage IV Ovaria... Stage IV Pancre... Stage IV Renal ... Stage IV Urethr... Stage IVA Cervi... Stage IVA Colon... Stage IVA Recta... Stage IVA Uteri... Stage IVB Cervi... Stage IVB Colon... Stage IVB Recta... Stage IVB Uteri... Ureter Cancer Stage IIA Lung ... Stage IIB Lung ... Stage IIIA Lung... Stage IIIB Lung...	educational int... telephone-based... quality-of-life... questionnaire a...	18 Years -	City of Hope Medical Center
Combination Chemotherapy and Bevacizumab Before Surgery and Radiolabeled Monoclonal Antibody Therapy in Treating Liver Metastases in Patients With Metastatic Colorectal Cancer	NCT01320683	Liver Metastase... Recurrent Colon... Recurrent Recta... Stage IVA Colon... Stage IVA Recta... Stage IVB Colon... Stage IVB Recta...	oxaliplatin leucovorin calc... fluorouracil bevacizumab yttrium Y 90 DO... laboratory biom... pharmacological... irinotecan hydr...	18 Years -	City of Hope Medical Center
Selumetinib and Cetuximab in Treating Patients With Refractory Solid Tumors	NCT01217450	Recurrent Colon... Recurrent Recta... Stage IVA Colon... Stage IVA Recta... Stage IVB Colon... Stage IVB Recta... Unspecified Adu...	selumetinib cetuximab laboratory biom... pharmacological...	18 Years -	National Cancer Institute (NCI)
S1417CD Financial Impact Assessment Tool in Patients With Metastatic Colorectal Cancer	NCT02728804	Stage IVA Colon... Stage IVA Recta... Stage IVB Colon... Stage IVB Recta...	Quality-of-Life... Questionnaire A...	18 Years -	SWOG Cancer Research Network
MEK Inhibitor MEK162 in Combination With Leucovorin Calcium, Fluorouracil, and Oxaliplatin in Treating Patients With Advanced Metastatic Colorectal Cancer	NCT02041481	Recurrent Colon... Recurrent Recta... Stage IVA Colon... Stage IVA Recta... Stage IVB Colon... Stage IVB Recta...	MEK inhibitor M... leucovorin calc... fluorouracil oxaliplatin pharmacological... Laboratory Biom...	18 Years -	City of Hope Medical Center
S1417CD Financial Impact Assessment Tool in Patients With Metastatic Colorectal Cancer	NCT02728804	Stage IVA Colon... Stage IVA Recta... Stage IVB Colon... Stage IVB Recta...	Quality-of-Life... Questionnaire A...	18 Years -	SWOG Cancer Research Network
Phase I-II Study of Fluorouracil in Combination With Phenylbutyrate in Advanced Colorectal Cancer	NCT00002796	Mucinous Adenoc... Mucinous Adenoc... Recurrent Colon... Recurrent Recta... Signet Ring Ade... Signet Ring Ade... Stage IVA Colon... Stage IVA Recta... Stage IVB Colon... Stage IVB Recta...	fluorouracil sodium phenylbu... indomethacin recombinant int...	-	National Cancer Institute (NCI)
Genotype-guided Dosing of mFOLFIRINOX Chemotherapy in Patients With Previously Untreated Advanced Gastrointestinal Malignancies	NCT01643499	Acinar Cell Ade... Adenocarcinoma ... Adenocarcinoma ... Adult Primary C... Advanced Adult ... Cholangiocarcin... Cholangiocarcin... Diffuse Adenoca... Duct Cell Adeno... Intestinal Aden... Localized Unres... Metastatic Carc... Metastatic Extr... Mixed Adenocarc... Mucinous Adenoc... Mucinous Adenoc... Newly Diagnosed... Signet Ring Ade... Signet Ring Ade... Stage III Pancr... Stage IIIA Colo... Stage IIIA Gall... Stage IIIA Gast... Stage IIIA Rect... Stage IIIB Colo... Stage IIIB Gall... Stage IIIB Gast... Stage IIIB Rect... Stage IIIC Colo... Stage IIIC Gast... Stage IIIC Rect... Stage IV Gastri... Stage IV Pancre... Stage IVA Colon... Stage IVA Gallb... Stage IVA Recta... Stage IVB Colon... Stage IVB Gallb... Stage IVB Recta... Unresectable Ex...	oxaliplatin irinotecan hydr... leucovorin calc... fluorouracil laboratory biom...	18 Years -	University of Chicago
Phase I Study of Cetuximab With RO4929097 in Metastatic Colorectal Cancer	NCT01198535	Colon Mucinous ... Colon Signet Ri... Rectal Mucinous... Rectal Signet R... Recurrent Colon... Recurrent Recta... Stage IVA Colon... Stage IVA Recta... Stage IVB Colon... Stage IVB Recta...	Cetuximab Gamma-Secretase... Laboratory Biom... Pharmacological...	18 Years -	National Cancer Institute (NCI)
Boronophenylalanine-Fructose Complex (BPA-F) and/or Sodium Borocaptate (BSH) Followed By Surgery in Treating Patients With Thyroid Cancer, Head and Neck Cancer, or Liver Metastases	NCT00062348	Colorectal Canc... Head and Neck C... Metastatic Canc...	boronophenylala... sodium borocapt... conventional su...	18 Years -	European Organisation for Research and Treatment of Cancer - EORTC
Sorafenib Tosylate, Bevacizumab, Irinotecan Hydrochloride, Leucovorin Calcium, and Fluorouracil in Treating Patients With Metastatic Colorectal Cancer	NCT01383343	Recurrent Colon... Recurrent Recta... Stage IVA Colon... Stage IVA Recta... Stage IVB Colon... Stage IVB Recta...	Bevacizumab Fluorouracil Irinotecan Hydr... Leucovorin Calc... Sorafenib Tosyl...	18 Years -	National Cancer Institute (NCI)
A Phase I, Pharmacological, and Biological Study of OSI-774 in Combination With FOLFOX 4 (5-FU, Leucovorin, and Oxaliplatin) and Bevacizumab (Avastin) in Patients With Advanced Colorectal Cancer	NCT00060411	Mucinous Adenoc... Mucinous Adenoc... Recurrent Colon... Recurrent Recta... Signet Ring Ade... Signet Ring Ade... Stage IIIA Colo... Stage IIIA Rect... Stage IIIB Colo... Stage IIIB Rect... Stage IIIC Colo... Stage IIIC Rect... Stage IVA Colon... Stage IVA Recta... Stage IVB Colon... Stage IVB Recta...	erlotinib hydro... fluorouracil leucovorin calc... oxaliplatin bevacizumab	18 Years -	National Cancer Institute (NCI)
Phase I Study of Cetuximab With RO4929097 in Metastatic Colorectal Cancer	NCT01198535	Colon Mucinous ... Colon Signet Ri... Rectal Mucinous... Rectal Signet R... Recurrent Colon... Recurrent Recta... Stage IVA Colon... Stage IVA Recta... Stage IVB Colon... Stage IVB Recta...	Cetuximab Gamma-Secretase... Laboratory Biom... Pharmacological...	18 Years -	National Cancer Institute (NCI)
Irinotecan-Eluting Beads in Treating Patients With Refractory Metastatic Colon or Rectal Cancer That Has Spread to the Liver	NCT02110953	Liver Metastase... Mucinous Adenoc... Mucinous Adenoc... Recurrent Colon... Recurrent Recta... Signet Ring Ade... Signet Ring Ade... Stage IVA Colon... Stage IVA Recta... Stage IVB Colon... Stage IVB Recta...	irinotecan-elut... hepatic artery ...	18 Years -	Fox Chase Cancer Center
Cediranib Maleate and Whole Brain Radiation Therapy in Patients With Brain Metastases From Non-Small Cell Lung Cancer	NCT00937482	Male Breast Can... Stage IV Breast... Stage IV Melano... Stage IV Non-sm... Stage IV Renal ... Stage IVA Colon... Stage IVA Recta... Stage IVB Colon... Stage IVB Recta... Tumors Metastat...	cediranib malea... whole-brain rad...	18 Years -	National Cancer Institute (NCI)
Phase I-II Study of Fluorouracil in Combination With Phenylbutyrate in Advanced Colorectal Cancer	NCT00002796	Mucinous Adenoc... Mucinous Adenoc... Recurrent Colon... Recurrent Recta... Signet Ring Ade... Signet Ring Ade... Stage IVA Colon... Stage IVA Recta... Stage IVB Colon... Stage IVB Recta...	fluorouracil sodium phenylbu... indomethacin recombinant int...	-	National Cancer Institute (NCI)
Sorafenib Tosylate, Bevacizumab, Irinotecan Hydrochloride, Leucovorin Calcium, and Fluorouracil in Treating Patients With Metastatic Colorectal Cancer	NCT01383343	Recurrent Colon... Recurrent Recta... Stage IVA Colon... Stage IVA Recta... Stage IVB Colon... Stage IVB Recta...	Bevacizumab Fluorouracil Irinotecan Hydr... Leucovorin Calc... Sorafenib Tosyl...	18 Years -	National Cancer Institute (NCI)
Irinotecan Compared With Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer	NCT00005036	Mucinous Adenoc... Mucinous Adenoc... Recurrent Colon... Recurrent Recta... Signet Ring Ade... Signet Ring Ade... Stage IIIA Colo... Stage IIIA Rect... Stage IIIB Colo... Stage IIIB Rect... Stage IIIC Colo... Stage IIIC Rect... Stage IVA Colon... Stage IVA Recta... Stage IVB Colon... Stage IVB Recta...	irinotecan hydr... oxaliplatin leucovorin calc... fluorouracil quality-of-life...	18 Years -	National Cancer Institute (NCI)
GTI-2040, Oxaliplatin, and Capecitabine in Treating Patients With Locally Advanced or Metastatic Colorectal Cancer or Other Solid Tumors	NCT00084643	Recurrent Colon... Recurrent Recta... Stage IIIC Colo... Stage IIIC Rect... Stage IVA Colon... Stage IVA Recta... Stage IVB Colon... Stage IVB Recta... Unspecified Adu...	GTI-2040 oxaliplatin capecitabine pharmacological... laboratory biom...	18 Years -	National Cancer Institute (NCI)
Combination Chemotherapy and Cetuximab or Bevacizumab in Treating Patients With Metastatic Colorectal Cancer	NCT01280643	Metastatic Colo...	fluorouracil leucovorin calc... oxaliplatin irinotecan hydr... bevacizumab cetuximab capecitabine mutation analys... gene expression... laboratory biom... immunohistochem... nucleic acid se... protein express... polymerase chai... DNA analysis	18 Years -	Fox Chase Cancer Center
Irinotecan and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic Colorectal Cancer That Progressed During First-Line Therapy	NCT00499369	Recurrent Colon... Recurrent Recta... Stage IVA Colon... Stage IVA Recta... Stage IVB Colon... Stage IVB Recta...	irinotecan hydr... leucovorin calc... fluorouracil cetuximab bevacizumab	18 Years -	National Cancer Institute (NCI)
Irinotecan Compared With Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer	NCT00005036	Mucinous Adenoc... Mucinous Adenoc... Recurrent Colon... Recurrent Recta... Signet Ring Ade... Signet Ring Ade... Stage IIIA Colo... Stage IIIA Rect... Stage IIIB Colo... Stage IIIB Rect... Stage IIIC Colo... Stage IIIC Rect... Stage IVA Colon... Stage IVA Recta... Stage IVB Colon... Stage IVB Recta...	irinotecan hydr... oxaliplatin leucovorin calc... fluorouracil quality-of-life...	18 Years -	National Cancer Institute (NCI)
SB-715992 in Treating Patients With Advanced or Metastatic Colorectal Cancer	NCT00103311	Recurrent Colon... Recurrent Recta... Stage IIIA Colo... Stage IIIA Rect... Stage IIIB Colo... Stage IIIB Rect... Stage IIIC Colo... Stage IIIC Rect... Stage IVA Colon... Stage IVA Recta... Stage IVB Colon... Stage IVB Recta...	ispinesib laboratory biom...	18 Years -	National Cancer Institute (NCI)
Bevacizumab and Cetuximab With or Without Irinotecan in Treating Patients With Irinotecan-Refractory Metastatic Colorectal Cancer	NCT00077298	Recurrent Colon... Recurrent Recta... Stage IVA Colon... Stage IVA Recta... Stage IVB Colon... Stage IVB Recta...	cetuximab bevacizumab irinotecan hydr... laboratory biom...	18 Years -	National Cancer Institute (NCI)
Selumetinib and Cetuximab in Treating Patients With Refractory Solid Tumors	NCT01217450	Recurrent Colon... Recurrent Recta... Stage IVA Colon... Stage IVA Recta... Stage IVB Colon... Stage IVB Recta... Unspecified Adu...	selumetinib cetuximab laboratory biom... pharmacological...	18 Years -	National Cancer Institute (NCI)
Ziv-Aflibercept Followed by Ziv-Aflibercept, Fluorouracil, and Leucovorin Calcium in Treating Patients With Stage IV Colorectal Cancer	NCT02235324	Mucinous Adenoc... Mucinous Adenoc... Recurrent Colon... Recurrent Recta... Signet Ring Ade... Signet Ring Ade... Stage IVA Colon... Stage IVA Recta... Stage IVB Colon... Stage IVB Recta...	ziv-aflibercept leucovorin calc... fluorouracil laboratory biom...	18 Years -	University of Southern California
Encorafenib, Binimetinib, and Nivolumab in Treating Microsatellite Stable BRAF V600E Metastatic Colorectal Cancer	NCT04044430	Metastatic Colo... Metastatic Colo... Metastatic Micr... Metastatic Rect... Stage III Colon... Stage III Color... Stage III Recta... Stage IIIA Colo... Stage IIIA Colo... Stage IIIA Rect... Stage IIIB Colo... Stage IIIB Colo... Stage IIIB Rect... Stage IIIC Colo... Stage IIIC Colo... Stage IIIC Rect... Stage IV Colon ... Stage IV Colore... Stage IV Rectal... Stage IVA Colon... Stage IVA Color... Stage IVA Recta... Stage IVB Colon... Stage IVB Color... Stage IVB Recta... Stage IVC Colon... Stage IVC Color... Stage IVC Recta...	Binimetinib Encorafenib Nivolumab Questionnaire A...	18 Years -	University of California, San Francisco
S1013: Validation of Cancer Questionnaire for Skin Toxicities in Patients With Colorectal Cancer or Lung Cancer Receiving Cetuximab, Panitumumab, or Erlotinib Hydrochloride	NCT01416688	Colorectal Canc... Dermatologic Co... Lung Cancer Therapy-related...	assessment of t... psychosocial as... quality-of-life...	18 Years - 120 Years	SWOG Cancer Research Network
Comprehensive Gene Sequencing in Guiding Treatment Recommendations Patients With Metastatic or Recurrent Solid Tumors	NCT01987726	Recurrent Breas... Recurrent Colon... Recurrent Recta... Stage IV Breast... Stage IVA Colon... Stage IVA Recta... Stage IVB Colon... Stage IVB Recta...	cytology specim... laboratory biom...	18 Years -	Ohio State University Comprehensive Cancer Center
A Trial of Maintenance ADAPT Therapy With Capecitabine and Celecoxib in Patients With Metastatic Colorectal Cancer	NCT01729923	Recurrent Colon... Recurrent Recta... Stage IVA Colon... Stage IVA Recta... Stage IVB Colon... Stage IVB Recta...	Capecitabine Celecoxib Intensity-Modul... Laboratory Biom... Quality-of-Life... Radiation Thera... Stereotactic Ra... Therapeutic Con...	18 Years -	University of Washington
PET-MRI in Diagnosing Patients With Colon or Rectal Cancer	NCT01807117	Recurrent Colon... Recurrent Recta... Stage IIA Colon... Stage IIA Recta... Stage IIB Colon... Stage IIB Recta... Stage IIC Colon... Stage IIC Recta... Stage IIIA Colo... Stage IIIA Rect... Stage IIIB Colo... Stage IIIB Rect... Stage IIIC Colo... Stage IIIC Rect... Stage IVA Colon... Stage IVA Recta... Stage IVB Colon... Stage IVB Recta...	positron emissi... computed tomogr... magnetic resona... fludeoxyglucose...	22 Years -	Case Comprehensive Cancer Center
Gamma-Secretase Inhibitor RO4929097 and Cediranib Maleate in Treating Patients With Advanced Solid Tumors	NCT01131234	Adult Anaplasti... Adult Anaplasti... Adult Anaplasti... Adult Brain Ste... Adult Giant Cel... Adult Glioblast... Adult Gliosarco... Adult Mixed Gli... Adult Solid Neo... Male Breast Car... Recurrent Adult... Recurrent Breas... Recurrent Colon... Recurrent Melan... Recurrent Non-S... Recurrent Ovari... Recurrent Ovari... Recurrent Pancr... Recurrent Recta... Recurrent Renal... Stage III Pancr... Stage III Renal... Stage IIIA Colo... Stage IIIA Non-... Stage IIIA Ovar... Stage IIIA Ovar... Stage IIIA Rect... Stage IIIA Skin... Stage IIIB Brea... Stage IIIB Colo... Stage IIIB Non-... Stage IIIB Ovar... Stage IIIB Ovar... Stage IIIB Rect... Stage IIIB Skin... Stage IIIC Brea... Stage IIIC Colo... Stage IIIC Ovar... Stage IIIC Ovar... Stage IIIC Rect... Stage IIIC Skin... Stage IV Breast... Stage IV Non-Sm... Stage IV Ovaria... Stage IV Ovaria... Stage IV Pancre... Stage IV Renal ... Stage IV Skin M... Stage IVA Colon... Stage IVA Recta... Stage IVB Colon... Stage IVB Recta...	Gamma-Secretase... Cediranib Malea... Pharmacological... Laboratory Biom...	18 Years -	National Cancer Institute (NCI)
Treated Blood Cells, Cyclophosphamide, Fludarabine Phosphate, and Aldesleukin in Treating Patients With Cancer	NCT01212887	Breast Cancer Colorectal Canc... Gastric Cancer Lung Cancer Ovarian Cancer Pancreatic Canc... Unspecified Adu...	MFE23 scFv-expr... aldesleukin cyclophosphamid... fludarabine pho... laboratory biom... pharmacological...	18 Years -	Cancer Research UK
Pan FGFR Kinase Inhibitor BGJ398 and Combination Chemotherapy in Treating Patients With Untreated Metastatic Pancreatic Cancer	NCT02575508	Colon Adenocarc... Metastatic Panc... Pancreatic Aden... Pancreatic Duct... Rectal Adenocar... Stage III Pancr... Stage IIIA Colo... Stage IIIA Rect... Stage IIIB Colo... Stage IIIB Rect... Stage IIIC Colo... Stage IIIC Rect... Stage IV Pancre... Stage IVA Colon... Stage IVA Recta... Stage IVB Colon... Stage IVB Recta...	Fluorouracil Irinotecan Hydr... Laboratory Biom... Oxaliplatin pan FGFR Kinase... Pharmacological...	18 Years -	Roswell Park Cancer Institute
Combination Chemotherapy and Cetuximab or Bevacizumab in Treating Patients With Metastatic Colorectal Cancer	NCT01280643	Metastatic Colo...	fluorouracil leucovorin calc... oxaliplatin irinotecan hydr... bevacizumab cetuximab capecitabine mutation analys... gene expression... laboratory biom... immunohistochem... nucleic acid se... protein express... polymerase chai... DNA analysis	18 Years -	Fox Chase Cancer Center
Genotype-guided Dosing of mFOLFIRINOX Chemotherapy in Patients With Previously Untreated Advanced Gastrointestinal Malignancies	NCT01643499	Acinar Cell Ade... Adenocarcinoma ... Adenocarcinoma ... Adult Primary C... Advanced Adult ... Cholangiocarcin... Cholangiocarcin... Diffuse Adenoca... Duct Cell Adeno... Intestinal Aden... Localized Unres... Metastatic Carc... Metastatic Extr... Mixed Adenocarc... Mucinous Adenoc... Mucinous Adenoc... Newly Diagnosed... Signet Ring Ade... Signet Ring Ade... Stage III Pancr... Stage IIIA Colo... Stage IIIA Gall... Stage IIIA Gast... Stage IIIA Rect... Stage IIIB Colo... Stage IIIB Gall... Stage IIIB Gast... Stage IIIB Rect... Stage IIIC Colo... Stage IIIC Gast... Stage IIIC Rect... Stage IV Gastri... Stage IV Pancre... Stage IVA Colon... Stage IVA Gallb... Stage IVA Recta... Stage IVB Colon... Stage IVB Gallb... Stage IVB Recta... Unresectable Ex...	oxaliplatin irinotecan hydr... leucovorin calc... fluorouracil laboratory biom...	18 Years -	University of Chicago
1st Line Chemotherapy Alone or With Bevacizumab in Treating Older Patients With Metastatic Colorectal Cancer	NCT01417494	Colorectal Canc...	Chemotherapy ( ... Chemotherapy ( ...	75 Years - 120 Years	Federation Francophone de Cancerologie Digestive
CPI-613 and Fluorouracil in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed by Surgery	NCT02232152	Mucinous Adenoc... Mucinous Adenoc... Recurrent Colon... Recurrent Recta... Signet Ring Ade... Signet Ring Ade... Stage IIIA Colo... Stage IIIA Rect... Stage IIIB Colo... Stage IIIB Rect... Stage IIIC Colo... Stage IIIC Rect... Stage IVA Colon... Stage IVA Recta... Stage IVB Colon... Stage IVB Recta...	6,8-bis(benzylt... fluorouracil pharmacological... laboratory biom...	18 Years -	Wake Forest University Health Sciences
MEK Inhibitor MEK162 in Combination With Leucovorin Calcium, Fluorouracil, and Oxaliplatin in Treating Patients With Advanced Metastatic Colorectal Cancer	NCT02041481	Recurrent Colon... Recurrent Recta... Stage IVA Colon... Stage IVA Recta... Stage IVB Colon... Stage IVB Recta...	MEK inhibitor M... leucovorin calc... fluorouracil oxaliplatin pharmacological... Laboratory Biom...	18 Years -	City of Hope Medical Center
SB-715992 in Treating Patients With Advanced or Metastatic Colorectal Cancer	NCT00103311	Recurrent Colon... Recurrent Recta... Stage IIIA Colo... Stage IIIA Rect... Stage IIIB Colo... Stage IIIB Rect... Stage IIIC Colo... Stage IIIC Rect... Stage IVA Colon... Stage IVA Recta... Stage IVB Colon... Stage IVB Recta...	ispinesib laboratory biom...	18 Years -	National Cancer Institute (NCI)
Linifanib in Treating Patients With Advanced, Refractory Colorectal Cancer	NCT01365910	Recurrent Colon... Recurrent Recta... Stage IVA Colon... Stage IVA Recta... Stage IVB Colon... Stage IVB Recta...	linifanib	18 Years -	Vanderbilt-Ingram Cancer Center
GTI-2040, Oxaliplatin, and Capecitabine in Treating Patients With Locally Advanced or Metastatic Colorectal Cancer or Other Solid Tumors	NCT00084643	Recurrent Colon... Recurrent Recta... Stage IIIC Colo... Stage IIIC Rect... Stage IVA Colon... Stage IVA Recta... Stage IVB Colon... Stage IVB Recta... Unspecified Adu...	GTI-2040 oxaliplatin capecitabine pharmacological... laboratory biom...	18 Years -	National Cancer Institute (NCI)
MEK Inhibitor MEK162 in Combination With Leucovorin Calcium, Fluorouracil, and Oxaliplatin in Treating Patients With Advanced Metastatic Colorectal Cancer	NCT02041481	Recurrent Colon... Recurrent Recta... Stage IVA Colon... Stage IVA Recta... Stage IVB Colon... Stage IVB Recta...	MEK inhibitor M... leucovorin calc... fluorouracil oxaliplatin pharmacological... Laboratory Biom...	18 Years -	City of Hope Medical Center
S1417CD Financial Impact Assessment Tool in Patients With Metastatic Colorectal Cancer	NCT02728804	Stage IVA Colon... Stage IVA Recta... Stage IVB Colon... Stage IVB Recta...	Quality-of-Life... Questionnaire A...	18 Years -	SWOG Cancer Research Network
Escitalopram in Treating Depression in Patients With Advanced Lung or Gastrointestinal Cancer	NCT00387348	Colorectal Canc... Depression Esophageal Canc... Extrahepatic Bi... Fatigue Gallbladder Can... Gastric Cancer Liver Cancer Lung Cancer Pancreatic Canc...	escitalopram ox... Placebo	35 Years - 85 Years	Massachusetts General Hospital
Akt Inhibitor MK2206 in Treating Patients With Previously Treated Colon or Rectal Cancer That is Metastatic or Locally Advanced and Cannot Be Removed by Surgery	NCT01802320	Colon Mucinous ... Colon Signet Ri... Rectal Mucinous... Rectal Signet R... Recurrent Colon... Recurrent Recta... Stage IIIA Colo... Stage IIIA Rect... Stage IIIB Colo... Stage IIIB Rect... Stage IIIC Colo... Stage IIIC Rect... Stage IVA Colon... Stage IVA Recta... Stage IVB Colon... Stage IVB Recta...	Akt Inhibitor M... Laboratory Biom... Pharmacological...	18 Years -	National Cancer Institute (NCI)
Programs to Support You During Chemotherapy (Pro-You)	NCT02148406	Depressive Symp... Fatigue Psychosocial Ef... Stage IIA Colon... Stage IIA Recta... Stage IIB Colon... Stage IIB Recta... Stage IIC Colon... Stage IIC Recta... Stage IIIA Colo... Stage IIIA Rect... Stage IIIB Colo... Stage IIIB Rect... Stage IIIC Colo... Stage IIIC Rect... Stage IVA Colon... Stage IVA Recta... Stage IVB Colon... Stage IVB Recta...	Yoga Skills Tra... questionnaire a... fatigue and dep... psychological s... laboratory biom... Attention Contr...	18 Years -	Vanderbilt-Ingram Cancer Center
Short-Infusion Ziv-aflibercept in Treating Patients With Metastatic Colorectal Cancer Receiving Combination Chemotherapy	NCT01941173	Recurrent Colon... Recurrent Recta... Stage IVA Colon... Stage IVA Recta... Stage IVB Colon... Stage IVB Recta...	ziv-aflibercept leucovorin calc... irinotecan hydr... fluorouracil	18 Years -	City of Hope Medical Center

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: